Concourse Financial Group Securities, Inc. Bluejay Diagnostics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$0.19 - $0.41 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.38 - $0.87 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.34 - $138.99 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.83 - $132.53 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.94 - $1.63 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.86 - $2.92 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$2.33 - $5.32 $0 - $0
0 New
0 $0

About Bluejay Diagnostics, Inc.

BJDX Quotes by TradingView
  • Ticker BJDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,152,300
  • Market Cap $3.63M
  • Description
  • Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...
More about BJDX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email